ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
| Autor: | Mikulska, M., Lanini, S., Gudiol, C., Drgona, L., Ippolito, G., Fernández-Ruiz, M., Salzberger, B. |
|---|---|
| Zdroj: | In Clinical Microbiology and Infection June 2018 24 Supplement 2:S71-S82 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|